Delphi-2M is the first open source, large-scale model for predicting a patient’s disease risk and when it may occur.
Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...
News-Medical.Net on MSN
Genetic risk scores fail to predict survival after diagnosis
Research indicates that disease susceptibility genetics poorly predict survival, while longevity PGSs offer stronger ...
This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.
Introduction Safe surgical care is a cost-effective intervention for addressing a wide range of conditions, yet postoperative ...
Across the Arabian Peninsula, home to the Gulf Cooperation Council (GCC) states, societies have transformed within a century ...
For the growing number of children with type 1 diabetes, the daily burden of managing their challenging chronic disease and ...
The Endocrine Society and European Society of Endocrinology issued recommendations for the management of preexisting diabetes ...
The management of type 1 diabetes (T1D) has entered a new era of general population screening and preventive interventions. Although islet autoantibodies ...
India Today on MSN
Diabetics can fly to space: Shubhanshu Shukla's Ax-4 mission breaks medical barrier
This finding opens the door for astronauts with diabetes to participate in space missions, a feat earlier considered ...
This three-part webinar series explores how cutting-edge AI, including foundation models, is being applied to drug discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results